Lixa
PrivateLast Round
VC Round
Jun 5, 2025
Total Funding Raised
$1.53M
Company Overview
Lixa is a biotechnology company that develops small-molecule resistance modulators designed to dismantle bacterial biofilms and restore the effectiveness of existing antimicrobial treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lixa Comparables
Compare Lixa with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioTryp Therapeutics | 78% | |
| Microbion Corporation | 74% | |
| QureTech Bio | 71% | |
Lixa Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 5, 2025 | ||||
| Grant | Aug 16, 2024 | ||||
| Seed | Sep 1, 2022 |
Key People
Founding team and executive leadership
Lixa Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Industries and Innovation Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 681% MoM.
- Dec 26, 2025
Grew 23% QoQ, from 13 to 16 employees.
Lixa Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lixa's valuation, stock price, and market status.